FDA accepts drug application for zipalertinib lung cancer treatment
Go back to FDA accepts drug application for zipalertinib lung cancer treatment| Consolidated Gems, Inc. (NASDAQ: CGEM) | Delayed: 17.75 +0.45 (2.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.30 | 52 Week High | $0.19 | |||
| Open | $16.80 | 52 Week Low | $0.03 | |||
| Day High | $17.98 | P/E | N/A | |||
| Day Low | $16.56 | EPS | $0.00 | |||
| Volume | 1,959,229 | |||||
